{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T19:54:58Z","timestamp":1773518098354,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,1]]},"DOI":"10.7759\/cureus.19192","type":"journal-article","created":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T19:20:56Z","timestamp":1635794456000},"source":"Crossref","is-referenced-by-count":1,"title":["Comparison of Efficacy of Ivabradine With Traditional Therapy in Patients With Left Ventricular Dysfunction"],"prefix":"10.7759","author":[{"given":"Umair","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanveer","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jehanzeb","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad ijaz","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hurriya","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bilal","family":"Javed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.119.313572","article-title":"Heart failure with preserved ejection fraction in perspective","volume":"124","author":"Pfeffer MA","year":"2019","unstructured":"Pfeffer MA, Shah AM, Borlaug BA. Heart failure with preserved ejection fraction in perspective. Circ Res. 2019, 124:1598-617. 10.1161\/CIRCRESAHA.119.313572","journal-title":"Circ Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2017.03.131","article-title":"Long-term treatment with ivabradine over 12months in patients with chronic heart failure in clinical practice: Effect on symptoms, quality of life and hospitalizations","volume":"240","author":"Zugck C","year":"2017","unstructured":"Zugck C, St\u00f6rk S, St\u00f6ckl G. Long-term treatment with ivabradine over 12months in patients with chronic heart failure in clinical practice: Effect on symptoms, quality of life and hospitalizations. Int J Cardiol. 2017, 240:258-64. 10.1016\/j.ijcard.2017.03.131","journal-title":"Int J Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afy194","article-title":"Frailty and co-morbidity predict first hospitalisation after heart failure diagnosis in primary care: population-based observational study in England","volume":"48","author":"Bottle A","year":"2019","unstructured":"Bottle A, Kim D, Hayhoe B, Majeed A, Aylin P, Clegg A, Cowie MR. Frailty and co-morbidity predict first hospitalisation after heart failure diagnosis in primary care: population-based observational study in England. Age Ageing. 2019, 48:347-54. 10.1093\/ageing\/afy194","journal-title":"Age Ageing"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2017.1259410","article-title":"Newer drugs for heart failure: hype or hope?","volume":"26","author":"Ghali JK","year":"2017","unstructured":"Ghali JK. Newer drugs for heart failure: hype or hope?. Expert Opin Investig Drugs. 2017, 26:5-7. 10.1080\/13543784.2017.1259410","journal-title":"Expert Opin Investig Drugs"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2017.1363729","article-title":"Heart rate control is associated with reduced cardiovascular events in Asian patients with coronary artery disease treated with bisoprolol (BISO-CAD): results from a multi-national, real-world experience","volume":"34","author":"Chen Y","year":"2018","unstructured":"Chen Y, Yang X, Nguyen Pham V, et al.. Heart rate control is associated with reduced cardiovascular events in Asian patients with coronary artery disease treated with bisoprolol (BISO-CAD): results from a multi-national, real-world experience. Curr Med Res Opin. 2018, 34:217-25. 10.1080\/03007995.2017.1363729","journal-title":"Curr Med Res Opin"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2020.07.031","article-title":"The rationale for repurposing funny current inhibition for management of ventricular arrhythmia","volume":"18","author":"Chakraborty P","year":"2021","unstructured":"Chakraborty P, Rose RA, Nair K, Downar E, Nanthakumar K. The rationale for repurposing funny current inhibition for management of ventricular arrhythmia. Heart Rhythm. 2021, 18:130-7. 10.1016\/j.hrthm.2020.07.031","journal-title":"Heart Rhythm"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg K","year":"2010","unstructured":"Swedberg K, Komajda M, B\u00f6hm M. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet. 2010, 376:875-85. 10.1016\/S0140-6736(10)61198-1","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2019.02.015","article-title":"Outcomes and effect of treatment according to etiology in HFrEF: an analysis of PARADIGM-HF","volume":"7","author":"Balmforth C","year":"2019","unstructured":"Balmforth C, Simpson J, Shen L, et al.. Outcomes and effect of treatment according to etiology in HFrEF: an analysis of PARADIGM-HF. JACC Heart Fail. 2019, 7:457-65. 10.1016\/j.jchf.2019.02.015","journal-title":"JACC Heart Fail"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2017.04.004","article-title":"Resting heart rate and the risk of cardiovascular disease, total cancer, and all-cause mortality - a systematic review and dose-response meta-analysis of prospective studies","volume":"27","author":"Aune D","year":"2017","unstructured":"Aune D, Sen A, \u00f3'Hartaigh B, Janszky I, Romundstad PR, Tonstad S, Vatten LJ. Resting heart rate and the risk of cardiovascular disease, total cancer, and all-cause mortality - a systematic review and dose-response meta-analysis of prospective studies. Nutr Metab Cardiovasc Dis. 2017, 27:504-17. 10.1016\/j.numecd.2017.04.004","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1406","article-title":"Mortality reduction associated with \u03b2-adrenoceptor inhibition in chronic heart failure is greater in patients with diabetes","volume":"41","author":"Witte KK","year":"2018","unstructured":"Witte KK, Drozd M, Walker AM, et al.. Mortality reduction associated with \u03b2-adrenoceptor inhibition in chronic heart failure is greater in patients with diabetes. Diabetes Care. 2018, 41:136-42. 10.2337\/dc17-1406","journal-title":"Diabetes Care"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.0640","article-title":"Assessment of limitations to optimization of guideline-directed medical therapy in heart failure from the GUIDE-IT trial: a secondary analysis of a randomized clinical trial","volume":"5","author":"Fiuzat M","year":"2020","unstructured":"Fiuzat M, Ezekowitz J, Alemayehu W, et al.. Assessment of limitations to optimization of guideline-directed medical therapy in heart failure from the GUIDE-IT trial: a secondary analysis of a randomized clinical trial. JAMA Cardiol. 2020, 5:757-64. 10.1001\/jamacardio.2020.0640","journal-title":"JAMA Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/2040622318784556","article-title":"The therapeutic role of ivabradine in heart failure","volume":"9","author":"Badu-Boateng C","year":"2018","unstructured":"Badu-Boateng C, Jennings R, Hammersley D. The therapeutic role of ivabradine in heart failure. Ther Adv Chronic Dis. 2018, 9:199-207. 10.1177\/2040622318784556","journal-title":"Ther Adv Chronic Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.18-559","article-title":"Ivabradine improves cardiac function and increases exercise capacity in patients with chronic heart failure","volume":"60","author":"Pei H","year":"2019","unstructured":"Pei H, Miao W, Xie WZ, Wang W, Zhao D, Su GH, Zhao Z. Ivabradine improves cardiac function and increases exercise capacity in patients with chronic heart failure. Int Heart J. 2019, 60:899-909. 10.1536\/ihj.18-559","journal-title":"Int Heart J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.347","article-title":"Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trial","volume":"17","author":"Komajda M","year":"2015","unstructured":"Komajda M, Tavazzi L, Francq BG, B\u00f6hm M, Borer JS, Ford I, Swedberg K. Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trial. Eur J Heart Fail. 2015, 17:1294-301. 10.1002\/ejhf.347","journal-title":"Eur J Heart Fail"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2015.1080155","article-title":"Effect of ivabradine on numbers needed to treat for the prevention of recurrent hospitalizations in heart failure patients","volume":"31","author":"Rogers JK","year":"2015","unstructured":"Rogers JK, Kielhorn A, Borer JS, Ford I, Pocock SJ. Effect of ivabradine on numbers needed to treat for the prevention of recurrent hospitalizations in heart failure patients. Curr Med Res Opin. 2015, 31:1903-9. 10.1185\/03007995.2015.1080155","journal-title":"Curr Med Res Opin"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/74597-comparison-of-efficacy-of-ivabradine-with-traditional-therapy-in-patients-with-left-ventricular-dysfunction","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:32:59Z","timestamp":1707507179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/74597-comparison-of-efficacy-of-ivabradine-with-traditional-therapy-in-patients-with-left-ventricular-dysfunction"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.19192","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,1]]}}}